FR3052063B1 - Composition cosmetique ou pharmaceutique destinee a augmenter le taux de melatonine endogene et de synchronisation des rytmes chronobiologiques - Google Patents

Composition cosmetique ou pharmaceutique destinee a augmenter le taux de melatonine endogene et de synchronisation des rytmes chronobiologiques Download PDF

Info

Publication number
FR3052063B1
FR3052063B1 FR1601321A FR1601321A FR3052063B1 FR 3052063 B1 FR3052063 B1 FR 3052063B1 FR 1601321 A FR1601321 A FR 1601321A FR 1601321 A FR1601321 A FR 1601321A FR 3052063 B1 FR3052063 B1 FR 3052063B1
Authority
FR
France
Prior art keywords
cosmetic
pharmaceutical composition
melatonin
rytmes
chronobiological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1601321A
Other languages
English (en)
Other versions
FR3052063A1 (fr
Inventor
Bejit Ideas
Etienne Soudant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actina
Original Assignee
Actina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actina filed Critical Actina
Publication of FR3052063A1 publication Critical patent/FR3052063A1/fr
Application granted granted Critical
Publication of FR3052063B1 publication Critical patent/FR3052063B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Abstract

Composition cosmétique ou pharmaceutique destinée à être utilisée par voie orale ou par voie topique et caractérisée en ce qu'elle associe Olea europaea, Rosmarinus officinalis et Phaseolus vulgaris et qu'elle augmente le taux de mélatonine endogène.
FR1601321A 2016-06-01 2016-09-08 Composition cosmetique ou pharmaceutique destinee a augmenter le taux de melatonine endogene et de synchronisation des rytmes chronobiologiques Active FR3052063B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1600890 2016-06-01
FR1600890A FR3052062A1 (fr) 2016-06-01 2016-06-01 Composition cosmetique ou pharmaceutique destinee a augmenter le taux de melatonine endogene et de synchronisation des rythmes chronobiologiques

Publications (2)

Publication Number Publication Date
FR3052063A1 FR3052063A1 (fr) 2017-12-08
FR3052063B1 true FR3052063B1 (fr) 2020-03-27

Family

ID=57960476

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1600890A Pending FR3052062A1 (fr) 2016-06-01 2016-06-01 Composition cosmetique ou pharmaceutique destinee a augmenter le taux de melatonine endogene et de synchronisation des rythmes chronobiologiques
FR1601321A Active FR3052063B1 (fr) 2016-06-01 2016-09-08 Composition cosmetique ou pharmaceutique destinee a augmenter le taux de melatonine endogene et de synchronisation des rytmes chronobiologiques

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR1600890A Pending FR3052062A1 (fr) 2016-06-01 2016-06-01 Composition cosmetique ou pharmaceutique destinee a augmenter le taux de melatonine endogene et de synchronisation des rythmes chronobiologiques

Country Status (1)

Country Link
FR (2) FR3052062A1 (fr)

Also Published As

Publication number Publication date
FR3052062A1 (fr) 2017-12-08
FR3052063A1 (fr) 2017-12-08

Similar Documents

Publication Publication Date Title
CO2020000145A2 (es) Carboxamidas como moduladores de los canales de sodio
CL2019000819A1 (es) Compuestos y composiciones para inhibir la actividad arginasa. (divisional solicitud 201801134)
MY196173A (en) Cot Modulators And Methods Of Use Thereof
MX2018005600A (es) Composiciones farmaceuticas y metodos para la inhibicion de indolamina 2,3-dioxigenasa e indicaciones para ello.
CL2018003302A1 (es) Uso de prg4 como agente antiinflamatorio. (divisional solicitud 201701893).
PH12016500024A1 (en) Bromodomain inhibitor
BR112015022545A2 (pt) compostos de pirazolo e os usos disso
CY1122113T1 (el) Φαρμακευτικες συνθεσεις για τη θεραπεια του ελικοβακτηριδιου του πυλωρου
BR112016001446A8 (pt) composições terapêuticas, produto de combinação, uso in vitro de flecainida e flecainida
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
NI201500115A (es) Estra-1,3,5(10), 16-tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
CL2011002766A1 (es) Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras.
BR112019025230A2 (pt) Anéis 5-5 fundidos como inibidores de c5a
MX2022001796A (es) Metodos y composiciones para inhibir los sintomas asociados con la veisalgia.
CL2017000845A1 (es) Inhibidores de gingipaina de lisina
BR112017022158A2 (pt) compostos, composições farmacêuticas e uso de um composto
MA49839B1 (fr) Inhibiteurs bicycliques de la histone déacétylase
BR112016028518A2 (pt) composições farmacêuticas que compreendem dgla e uso do mesmo
AR112291A1 (es) Composición para su uso en la prevención y/o el tratamiento de la mucositis orogastrointestinal inducida por un tratamiento oncológico
CO2019007671A2 (es) Una composición farmacéutica que comprende un derivado de oxazina y su uso en el tratamiento o la prevención de la enfermedad de alzheimer
FR3052063B1 (fr) Composition cosmetique ou pharmaceutique destinee a augmenter le taux de melatonine endogene et de synchronisation des rytmes chronobiologiques
BR112016026422A2 (pt) solução farmacêutica compreendendo dopamina para uso no tratamento da doença de parkinson
CL2015001368A1 (es) Metodo para anticoncepcion controlada que comprende administrar una preparacion farmaceutica que comprende levonorgestrel y un inhibidor de la cox; uso de la composicion farmaceutica en la anticoncepcion "a la carta".
EA201900245A1 (ru) Нестероидное противовоспалительное средство на основе напроксена, обладающее низкой гастротоксичностью
MX2014005152A (es) Composicion farmaceutica para el tratamiento de alopatias relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20171208

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8